Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Early Cognitive Changes After Same-day Discharge Hip and Knee Arthroplasty

17. juni 2026 opdateret af: Abdullahi Abdirisak Hirsi, Odense University Hospital

Early Cognitive Changes in Patients Aged 70 Years or Older After Same-day Discharge Hip and Knee Arthroplasty: A Prospective Cohort Study

The goal of this observational study is to explore early cognitive changes in patients aged 70 years or older undergoing same-day discharge after hip or knee replacement surgery. The main question it aims to answer is:

Does patients experience cognitive changes in cognitive test performance from before surgery to the first day after surgery?

Participants will:

  • Complete a cognitive test battery virtually about 14 days before surgery, and on the first and seventh day after their operation.
  • Record pain levels and pain medicine use during the first week after surgery

Studieoversigt

Detaljeret beskrivelse

Introduction Background Postoperative cognitive dysfunction (POCD) is a prevalent complication in elderly patients and has significant clinical and socioeconomic consequences, delayed recovery, decreased quality of life, persistent neurocognitive disorders and increased morbidity and mortality within the first year of surgery . The pathogenesis remains poorly understood, partly due to varying diagnostic approaches and methodologies. Nevertheless, there is consensus that POCD is multifactorial influenced by factors such as advanced age, sleep disturbances, and inadequate perioperative pain management .

Sleep deprivation, in particular, can exacerbate hyperalgesia, impair cognition, and lead to increased respiratory and cardiac risks due to REM sleep rebound. Fast-track surgical protocols, which emphasize multimodal rehabilitation-including regional anesthesia, opioid-sparing analgesia, and early mobilization-have been shown to reduce postoperative pain, sleep disturbances, and the risk of delirium. These protocols have reduced the average length of hospital stays worldwide. In Denmark length of hospital stay after total hip arthroplasty (THA), total knee arthroplasty (TKA) and unicompartmental knee (UKA) is now only one day and an increasing number of patients are discharged on the day of surgery. Same-day discharge enable earlier return to a familiar environment and potentially enhanced pathophysiological recovery.

No studies have described early postoperative cognitive test performance in elderly patients undergoing same-day discharge hip and knee arthroplasty. This study therefore aims to address this knowledge gap by examining early cognitive changes in patients aged ≥70 years after same-day discharge hip and knee arthroplasty.

Aim The primary aim of this study is to report early cognitive changes measured with Symbol Digit Modality Test (SDMT) in patients over 70 years undergoing same-day discharge THA, TKA and UKA. Secondary, to report cognitive changes using the Stroop Color Test and verbal fluency test as well as patient's perceived cognitive function. As patients return home on the day of surgery in this contemporary same-day discharge arthroplasty setting, we hypothesize that early postoperative changes in cognitive performance will be limited compared with earlier fast-track studies with a longer median length of stay (LOS).

Methods

The cognitive tests:

The cognitive tests will be administered by research assistants with prior research experience.

Eligible participants will be recruited from the outpatient clinic. Testing will be performed virtually with the patients being at home. The patients will receive instructions to complete all sessions in the same quiet room and on the same device, to keep environmental stimuli (lighting, background noise, screen distance, seating, posture, and internet conditions) constant and thereby reduce within-subject variance and practice effects. The baseline test will be administered 14 days +- 3 days prior to surgery to avoid preoperative anxiety effects. Postoperatively, testing will be carried out on postoperative day 1 and day 7. More frequent testing is avoided to reduce practice effects.

Only patients receiving spinal anesthesia will be included to minimize confounding from general anesthesia and to reflect current fast-track practice. Spinal anesthesia is administered using a relatively short-acting blockade bupivacaine 5 mg/mL, 2.5 mL (12.5 mg) in THA, while for primary TKA and UKA, bupivacaine 5 mg/mL, 2 mL (10 mg) . Standard local infiltration analgesia (LIA) will be used with 150 mL ropivacaine 2 mg/mL in knee arthroplasties but not in hip arthroplasties . Peripheral nerve blocks are not used. Patients will also receive cloxacillin 2 gr, methylprednisolone 125 mg and 1 gr tranexamic acid intravenously immediately prior to skin incision.

Postoperative pain management and other medication Postoperative pain management will follow a standardized multimodal, opioid-sparing regimen. All patients will receive paracetamol (1 g × 4) in combination with ibuprofen 400 mg × 3 (7 days) for THA patients in and 400 mg × 4 (14 days) for TKA and UKA patients, unless contraindicated.

Opioids will be reserved as rescue medication, administered only on an "as needed" basis. Morphine 10 mg tablets will be used as first-line rescue analgesia, with oxycodone 5 mg as an alternative for patients who do not tolerate morphine.

Data Source:

A REDCap database has been established in collaboration with the Open Patient Data Explorative Network (OPEN) at Odense University Hospital (25). Patients scheduled for hip and knee arthroplasty at Svendborg hospital and included in the planned study will be enrolled in the database following informed consent. Patient's baseline database will be registered on comorbidities and medication use entered by trained research staff.

Statistics and sample size Although this is an exploratory study, the sample size was guided by considerations from both the literature and our pilot planning. Because the design is paired, each participant serves as their own control (baseline vs. postoperative assessment). For the SDMT we assumed a minimal clinically important difference (MCID) of 4 points , a within-subject correlation of 0.85 between baseline and postoperative scores, and a standard deviation of 7.5 . With a two-sided alpha of 0.05 and 80% power, this corresponds to approximately 14 participants with complete paired measurements per subgroup (THA, TKA, and UKA) if analyses are performed separately. To account for anticipated dropout/non-same-day discharge, we will aim to enroll 16 patients per subgroup to obtain 14 participants with complete paired measurements.

Continuous variables will be summarized as mean with standard deviation (SD) and range if approximately normally distributed; otherwise as median with interquartile range (IQR) and range. Categorical variables will be described using absolute and relative frequencies (n, %).

Patient involvement Patients who have previously undergone hip or knee arthroplasty were involved in the design process. Their feedback informed the research questions and outcome measures, ensuring relevance and patient-centeredness. During pilot testing, participating patients also provided input on the planned assessment procedures and overall feasibility, which further informed methodological adjustments.

Undersøgelsestype

Observationel

Tilmelding (Anslået)

48

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Studiesteder

      • Svendborg, Danmark, 5700
        • Rekruttering
        • Odense University Hospital, Svendborg Hospital
        • Kontakt:
        • Kontakt:
        • Ledende efterforsker:
          • Abdullahi Abdirisak Hirsi, MD

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Ældre voksen

Tager imod sunde frivillige

Ingen

Prøveudtagningsmetode

Ikke-sandsynlighedsprøve

Studiebefolkning

Patients scheduled for hip or knee arthroplasty at Svendborg hospital, Denmark.

Beskrivelse

Inclusion Criteria:

  • Unilateral elective primary Total Hip Arthroplasty, Total Knee Arthroplasty, or Unicompartmental Knee
  • Native Danish speaker
  • Spinal anesthesia

Exclusion Criteria:

  • Inability or unwillingness to provide informed consent
  • Inability to comply with virtual study procedures or follow-up sessions, including because of visual or hearing impairment
  • Known dementia or other diagnosed cognitive disorders or Brief Assessment of Impaired Cognition (BASIC)≤20
  • Parkinson's disease or other neurological conditions causing functional impairment
  • History of alcohol abuse (≥35 units per week)
  • Daily use of anxiolytics or hypnotics
  • Not discharged on the day of surgery

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

Kohorter og interventioner

Gruppe / kohorte
Total Hip Arthroplasty
Patients aged 70 years or older undergoing elective unilateral total hip arthroplasty with planned discharge on the day of surgery.
Total Knee Arthroplasty
Patients aged 70 years or older undergoing elective unilateral total knee arthroplasty with planned discharge on the day of surgery.
Unicompartmental Knee Arthroplasty
Patients aged 70 years or older undergoing elective unilateral unicompartmental knee arthroplasty with planned discharge on the day of surgery.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Change in Symbol Digit Modalities Test (SDMT) score from baseline to postoperative day 1.
Tidsramme: From baseline, 14 days before surgery, and postoperative day 1.
The SDMT is a validated neuropsychological tool that measures processing speed, attention, and visual scanning. The SDMT will be administered virtually as an oral 90-second test. The primary metric will be the SDMT score, defined as the number of correct digit substitutions completed within 90 seconds
From baseline, 14 days before surgery, and postoperative day 1.

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Change in Stroop Color-Word Test score from baseline to postoperative day 1.
Tidsramme: From baseline, 14 days before surgery, and postoperative day 1.
The Stroop Color-Word Test is a validated measure of selective attention and susceptibility to interference. The primary metrics will be completion time (seconds) and number of errors recorded for each session.
From baseline, 14 days before surgery, and postoperative day 1.
Change in Stroop Color-Word Test score from baseline to postoperative day 7.
Tidsramme: From baseline, 14 days before surgery, and postoperative day 7.
The Stroop Color-Word Test is a validated measure of selective attention and susceptibility to interference. The primary metrics will be completion time (seconds) and number of errors recorded for each session.
From baseline, 14 days before surgery, and postoperative day 7.
Change in Verbal fluency assessment score from baseline to postoperative day 1.
Tidsramme: From baseline, 14 days before surgery, and postoperative day 1.
Verbal fluency assessment is a validated test which assesses executive function, semantic memory, and language. In our test a semantic (animal naming) and a phonemic (letter S) fluency task were used, each administered for 60 seconds. Number of correct responses for each task will be registered.
From baseline, 14 days before surgery, and postoperative day 1.
Reporting patient-reported cognitive function on postoperative day 1.
Tidsramme: Postoperative day 1.
A brief two-item subjective cognitive questionnaire will be administered to assess patient's perceived cognitive changes and to identify any discrepancy between subjective experience and objective neuropsychological test performance.
Postoperative day 1.
Change in Symbol Digit Modalities Test (SDMT) score from baseline to postoperative day 7.
Tidsramme: From baseline, 14 days before surgery, and postoperative day 7.
The SDMT is a validated neuropsychological tool that measures processing speed, attention, and visual scanning. The SDMT will be administered virtually as an oral 90-second test. The primary metric will be the SDMT score, defined as the number of correct digit substitutions completed within 90 seconds
From baseline, 14 days before surgery, and postoperative day 7.
Change in Verbal fluency assessment score from baseline to postoperative day 7.
Tidsramme: From baseline, 14 days before surgery, and postoperative day 7.
Verbal fluency assessment is a validated test which assesses executive function, semantic memory, and language. In our test a semantic (animal naming) and a phonemic (letter S) fluency task were used, each administered for 60 seconds. Number of correct responses for each task will be registered.
From baseline, 14 days before surgery, and postoperative day 7.
Change in patient-reported cognitive function from postoperative day 1 to postoperative day 7.
Tidsramme: From postoperative day 1 and postoperative day 7.
A brief two-item subjective cognitive questionnaire will be administered to assess patient's perceived cognitive changes and to identify any discrepancy between subjective experience and objective neuropsychological test performance.
From postoperative day 1 and postoperative day 7.

Andre resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Cumulative In-hospital postoperative morphine consumption
Tidsramme: End of surgery until discharge from the hospital on the day 1 of surgery (DOS)
Measured in milligrams
End of surgery until discharge from the hospital on the day 1 of surgery (DOS)
Postoperative pain intensity during rest once a day.
Tidsramme: From postoperative day 1 to postoperative day 7.
Patients will record pain intensity using an 11-point numeric rating scale (NRS, 0-10) in a pain diary.
From postoperative day 1 to postoperative day 7.
Postoperative pain intensity during activity once a day
Tidsramme: From postoperative day 1 to postoperative day 7.
Patients will record pain intensity using an 11-point numeric rating scale (NRS, 0-10) in a pain diary. Pain will be assessed defined as a standardized 5-m walk test.
From postoperative day 1 to postoperative day 7.
Cumulative postoperative morphine consumption
Tidsramme: Postoperative day 1 to postoperative day 7.
Measured in milligrams.
Postoperative day 1 to postoperative day 7.

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Ledende efterforsker: Martin Lindberg-Larsen, Professor, Head of Research / Consultant Orthopaedic Surgeon at Odense University Hospital. Department of Clinical Research, University of Southern Denmark (SDU)

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Generelle publikationer

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

18. maj 2026

Primær færdiggørelse (Anslået)

31. oktober 2026

Studieafslutning (Anslået)

30. november 2026

Datoer for studieregistrering

Først indsendt

14. maj 2026

Først indsendt, der opfyldte QC-kriterier

19. maj 2026

Først opslået (Faktiske)

20. maj 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

22. juni 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

17. juni 2026

Sidst verificeret

1. juni 2026

Mere information

Begreber relateret til denne undersøgelse

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

IPD-planbeskrivelse

Individual participant data will not be publicly shared due to Danish data protection regulations and the nature of the clinical dataset. De-identified data may be made available from the investigators upon reasonable request and subject to applicable approvals.

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

3
Abonner